Junmin Wu
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Epidemiology top 5%
- Autophagy in Disease and Therapy
Papers in
-
- DNA Repair Mechanisms 3
- PI3K/AKT/mTOR signaling in cancer 3
- Ubiquitin and proteasome pathways 2
- Oncology 7
- Cancer-related Molecular Pathways 4
- Co-authors
- Tullia Lindsten (5 shared papers)Craig B. Thompson (4 shared papers)Steven L. Reiner (2 shared papers)Julie Chaix (1 shared paper)Scott M. Gordon (1 shared paper)Joseph C. Sun (1 shared paper)Levi J. Rupp (1 shared paper)Sharline Madera (1 shared paper)
- Journals
- Cancer Research (3 papers)Nature Communications (1 paper)Journal of Hematology & Oncology (1 paper)Cell Reports (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Junmin Wu
28 papers receiving 2.3k citations
Junmin Wu's Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 704
- Epidemiology 650
- Physiology 95
- Cancer Research 233
- Molecular Biology 990
Countries citing papers authored by Junmin Wu
This map shows the geographic impact of Junmin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Wu more than expected).
Fields of papers citing papers by Junmin Wu
This network shows the impact of papers produced by Junmin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Wu. The network helps show where Junmin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junmin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation Hit paper breakdown → | 2012 | 580 |
| 2 | 2008 | 456 | |
| 3 | 2011 | 282 | |
| 4 | Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. | 1998 | 154 |
| 5 | 2005 | 152 | |
| 6 | 2011 | 81 | |
| 7 | 2013 | 75 | |
| 8 | 2005 | 66 | |
| 9 | 2020 | 64 | |
| 10 | The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras. | 2001 | 60 |
| 11 | 2013 | 50 | |
| 12 | 2000 | 33 | |
| 13 | 2020 | 31 | |
| 14 | 2020 | 30 | |
| 15 | 2005 | 24 | |
| 16 | 2021 | 22 | |
| 17 | 2015 | 21 | |
| 18 | 2019 | 18 | |
| 19 | 2008 | 14 | |
| 20 | 2018 | 13 |
About Junmin Wu
Junmin Wu is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Epidemiology, having authored 28 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers), Immune Cell Function and Interaction (3 papers), Autophagy in Disease and Therapy (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Ubiquitin and proteasome pathways (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (704 citations), Epidemiology (650 citations), Physiology (95 citations), Cancer Research (233 citations) and Molecular Biology (990 citations). Junmin Wu has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Tullia Lindsten, Craig B. Thompson, Steven L. Reiner, Julie Chaix, Scott M. Gordon, Joseph C. Sun, Levi J. Rupp, Sharline Madera, Eric J. Bernhard and W. Gillies McKenna. Their work appears in journals such as Cancer Research, Nature Communications, Journal of Hematology & Oncology, Cell Reports and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.